Cargando…

Renal function and thromboprophylaxis in critically ill patients

Detalles Bibliográficos
Autores principales:	Scholey, Gareth M, Saayman, Anton G, Hingston, Christopher D, Wise, Matt P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911697/ https://www.ncbi.nlm.nih.gov/pubmed/20497594 http://dx.doi.org/10.1186/cc8985

Ejemplares similares

Bedside handover of critically ill patients
por: Wise, Matt P, et al.
Publicado: (2012)

Minimising drug errors in critically ill patients
por: Carson-Stevens, Andrew, et al.
Publicado: (2011)

Direct effects of modest hyperglycaemia on susceptibility to infection in the critically ill patient
por: Wise, Matt P, et al.
Publicado: (2008)

Latent viral infections in critically ill patients
por: Wise, Matt P, et al.
Publicado: (2009)

Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
por: Piagnerelli, Michaël, et al.
Publicado: (2020)

Impact of nystatin on Candida and the oral microbiome
por: Hingston, Christopher D, et al.
Publicado: (2012)

Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
por: de Montmollin, Etienne, et al.
Publicado: (2021)

Duration of antibiotic therapy in bacteraemia
por: Wise, Matt P, et al.
Publicado: (2012)

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?
por: Gurjar, Mohan
Publicado: (2014)

Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
por: Jonmarker, Sandra, et al.
Publicado: (2020)

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection
por: Kummer, R.L., et al.
Publicado: (2021)

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit
por: Lauzier, François, et al.
Publicado: (2014)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial
por: Pai, Menaka, et al.
Publicado: (2018)

Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis
por: Li, Guowei, et al.
Publicado: (2016)

What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
por: Cauchie, Philippe, et al.
Publicado: (2021)

The utility of open lung biopsy in critically ill adult patients
por: Weaver, C, et al.
Publicado: (2004)

Thromboprophylaxis strategies for COVID-19 patients
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
por: Cook, Deborah, et al.
Publicado: (2008)

Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials
por: Park, Jonghanne, et al.
Publicado: (2016)

Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection
por: Fattorutto, Maurizio, et al.
Publicado: (2021)

Acute renal failure in critically ill HIV-infected patients
por: Lopes, José António, et al.
Publicado: (2007)

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
por: MacDougall, Kira, et al.
Publicado: (2020)

Atypical antipsychotics and delirium in critical care
por: Wise, Matt P, et al.
Publicado: (2011)

Renal replacement therapy: is it effective in critically ill patients with acute kidney injury?
por: Schiffl, Helmut, et al.
Publicado: (2013)

Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
por: Lim, So Yeon, et al.
Publicado: (2013)

High level of venous thromboembolism in critically ill trauma patients despite early and well-driven thromboprophylaxis protocol
por: Hamada, S. R., et al.
Publicado: (2017)

A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data
por: Alrashed, Ahmed, et al.
Publicado: (2022)

Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach
por: Sahle, Berhe W., et al.
Publicado: (2023)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

An assessment of the RIFLE criteria for acute renal failure in critically ill HIV-infected patients
por: Lopes, José António, et al.
Publicado: (2007)

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
por: Ferrandis, R., et al.
Publicado: (2023)

Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
por: Alavi-Darazam, Ilad, et al.
Publicado: (2022)

Transcutaneous (tcCO(2)) measurement versus arterial blood gas CO(2 )measurement in critically ill adult patients
por: Weaver, C, et al.
Publicado: (2004)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g91hcsut0jspv0j04bpd2gu4hb